EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma

Melody B Oncale, Hossein Maymani, Loretta J Nastoupil

Blood and Lymphatic Cancer: Targets and Therapy · 2017

DOI: 10.2147/blctt.s110665 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2017. Verfasst von Melody B Oncale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, lnastoupil@mdan…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hodgkin lymphomalymphomanivolumabpembrolizumabprogrammed death-1

Autor:innen und Institutionen

  • Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, lnastoupil@mdanderson.org.

Zitieren

APA

Oncale, M. B., Maymani, H., & Nastoupil, L. J. (2017). Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s110665

Vancouver

Oncale MB, Maymani H, Nastoupil LJ. Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. 2017. doi:10.2147/blctt.s110665

BibTeX
@article{Oncale2017,
  author = {Oncale, Melody B and Maymani, Hossein and Nastoupil, Loretta J},
  title = {Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2017},
  doi = {10.2147/blctt.s110665}
}
Kostenlos starten →